Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Biofrontera Inc. reported the fiscal year ended December 31, 2025 results: revenue $41.7 million, net income $10.5 million.
- Period
- the fiscal year ended December 31, 2025
- Revenue
- $41.7 million
- Net income
- $10.5 million
- Result
- reported results
Exact text from the filing
GAAP to non-GAAP reconciliation of Adjusted EBITDA for the fourth quarters of 2025 and 2024. Full Year 2025 Financial Results Total revenues for full year 2025 increased 12% to $41.7 million compared with $37.3 million for the full year 2024. Gross profit margin for the full year 2025 was 73.7% compared to 50.1% for the prior year. Cost of goods sold related party
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Biofrontera Inc. reported the fourth quarter ended December 31, 2025 results: revenue $17.1 million, net income $5.6 million.
- Period
- the fourth quarter ended December 31, 2025
- Revenue
- $17.1 million
- Net income
- $5.6 million
- Result
- reported results
Exact text from the filing
financial results for the three and twelve months ended December 31, 2025 and provided a business update. Fourth Quarter Financial Highlights ● Revenues for 4Q25 were a record $17.1 million, a 36% increase compared to $12.6 million for the same period in 2024. ● Gross margins were 82.4%, a roughly 2,400 basis point year over year increase compared to 58.0% in
View on SEC.gov